The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Clinical

The Cancer Letter receives investigative, design awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The Cancer Letter received five 2020 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists:

  • Art/Photo Illustration, Newsletter/Trade Publications, first place, by Katie Goldberg, for illustrations of the 2019 ASCO annual meeting

  • Editorial Cartooning, Newsletter/Trade Publications, first place, by Katie Goldberg

  • Infographic, Newsletter/Trade Publications, first place, by Jacqueline Ong

  • Art/Photo Illustration, Newsletter/Trade Publications, finalist, by Katie Goldberg, for cover art of 2019

  • Investigative Journalism, Newsletter/Trade Publications, finalist, for “Thirty Days to Death by Cancer,” by Matthew Ong and Paul Goldberg

This is the third consecutive year The Cancer Letter has won first-place design awards, and the first year The Cancer Letter has won awards for cartooning and infographics.

This is also the fourth award Ong has received from SPJDC for his series on cancer-related surgical outcomes, minimally invasive surgery, FDA regulation of devices, and new surgical techniques for the prevention or treatment of cancer.

Here are a few of The Cancer Letter‘s award-winning covers, cartoons, and infographics published in 2019:

story12

Table of Contents

YOU MAY BE INTERESTED IN

PodcastThe Directors

The Directors: Wistar’s Altieri and ChristianaCare’s Petrelli say partnership of their institutions will go on as the guard changes

Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019). 
By Sara Willa Ernst and Paul Goldberg
Trials & Tribulations

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

March is National Colorectal Cancer Awareness Month. It is a reminder of a heartbreaking trend that oncologists like me are witnessing in our clinics: Last year, for the first time, colorectal cancer became the leading cause of cancer-related death in Americans under the age of 50, according to data published earlier this year in JAMA.
By Richard M. Goldberg
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account